top of page
Unprecedented Sensitivity
With an unparalleled sensitivity and specificity, LiquiDyne can detect asymptomatic stage 1 and 2 lung and pancreatic cancers.
1-Day Turnaround Time
Without any need for pretreatment, LiquiDyne can yield results within
1 day upon receipt of blood plasma.
Cost Effective Screening
Compared to conventional NGS and PCR, LiquiDyne is at least
3x more cost-effective.
Seamless Work Flow Integration
LiquiDyne can join your preexisting panels with a very low amount of blood plasma. (20 microliters)
1-Day Turnaround Time
Increase in
5-Year Survival Rate
15X
Pancreatic
Cancer
16X
Lung
Cancer
Treatment Cost Savings from Early Detection
$300K+
$300K+
Pancreatic
Cancer
Lung
Cancer
Unparallelled Sensitivity and Specificity
LiquiDyne provided unprecedented level of sensitivity and specificity in
detecting cancer mutations through blood biopsy.
Blood Plasma Testing
with No Pretreatment
LilquiDyne does not need lengthy preparation process that cause sample losses.
Interested in ultra-sensitive
solution for your decision making?
Learn more about how LiquiDyne can help your needs.
bottom of page